BriaCell Resolution of Lung Metastasis in First Patient treated with Bria-OTS

 

• Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ monotherapy
• No toxicity related to the treatment; Patient remains on study
• Unprecedented result in first patient dosed supports Bria-OTS™ personalized immunotherapy approach
• Ongoing Phase 1/2a dose escalation study to evaluate Bria-OTS™, BriaCell's personalized off-the-shelf immunotherapy in metastatic breast cancer

https://www.globenewswire.com/news-release/2025/02/03/3019425/0/en/BriaCell-Announces-Resolution-of-Lung-Metastasis-in-First-Patient-treated-with-Bria-OTS.html